Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C74547
http://purl.obolibrary.org/obo/NCIT_C74547
|
|---|---|
| Preferred Name | Pazopanib |
| Definitions |
A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated. |
|---|---|
| prefLabel | Pazopanib
|
| label | Pazopanib
|
| Has_Salt_Form | |
| code | C74547
|
| Has_Target | |
| prefixIRI | NCIT:C74547
|
| in_subset | |
| Preferred_Name | Pazopanib
|
| FDA_UNII_Code | 7RN5DR86CK
|
| Contributing_Source | FDA
|
| Chemical_Formula | C21H23N7O2S
|
| Maps_To | Pazopanib
|
| CAS_Registry |
444731-52-6
790713-33-6
|
| Legacy Concept Name | Pazopanib_Base
|
| type | |
| ALT_DEFINITION | A drug that is used to treat kidney cancer and is being studied in the treatment of other types of cancer. It may prevent the growth of new blood vessels that tumors need to grow. It is a type of protein tyrosine kinase inhibitor and a type of antiangiogenesis agent.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C1831796
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |